Singapore kicks off drug rule revisions with proposals on advertising
This article was originally published in SRA
Executive Summary
Singapore's Health Sciences Authority is seeking comments on a proposal to replace its pre-approval system for drug advertisements with a new mechanism that would allow the pharmaceutical industry to self-regulate based on a set of rules and guiding principles1-4.